Similar articles

• Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.

  Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RL, Robertson L, Donovan A, Gaffney T, Bertele V, Troll J, et al. Salzman EW, et al. N Engl J Med. 1986 May 29;314(22):1402-6. doi: 10.1056/NEJM198605293142202. N Engl J Med. 1986. PMID: 3517650 Clinical Trial.
• A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.

  Hackmann T, Gascoyne RD, Naiman SC, Growe GH, Burchill LD, Jamieson WR, Sheps SB, Schechter MT, Townsend GE. Hackmann T, et al. N Engl J Med. 1989 Nov 23;321(21):1437-43. doi: 10.1056/NEJM198911233212104. N Engl J Med. 1989. PMID: 2682243 Clinical Trial.
• The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children.

  Seear MD, Wadsworth LD, Rogers PC, Sheps S, Ashmore PG. Seear MD, et al. J Thorac Cardiovasc Surg. 1989 Aug;98(2):217-9. J Thorac Cardiovasc Surg. 1989. PMID: 2666759 Clinical Trial.
• Desmopressin acetate in postoperative bleeding.

  Smith RC. Smith RC. DICP. 1990 May;24(5):475-6. DICP. 1990. PMID: 2188433 Review. No abstract available.
• Pro: desmopressin is of value in the treatment of post-cardiopulmonary bypass bleeding.

  Shiffrin JS, Glass DD. Shiffrin JS, et al. J Cardiothorac Vasc Anesth. 1991 Jun;5(3):285-9. doi: 10.1016/1053-0770(91)90290-a. J Cardiothorac Vasc Anesth. 1991. PMID: 1863750 Review. No abstract available.